The role of the rectal exam in prostate cancer screening questioned.
Posted by giorgiobertin on January 20, 2024
A study of Comprehensive Cancer Center Vienna of MedUni Vienna and the Vienna General Hospital took a closer look at the effectiveness of common testing methods for the early detection of prostate cancer. The rectal exam has been found to have no advantages over the PSA blood test for detecting prostate cancer.
A new study analyzed data from eight different studies, involving a total of 85,738 participants, and suggested that digital rectal examination (DRE) alone or in combination with PSA testing may no longer be effective in early diagnosis of prostate cancer compared to PSA testing alone. The results indicate that the DRE showed a lower cancer detection rate than the PSA test.
This raises questions about the effectiveness of digital rectal examination in routine prostate cancer screening, especially in the absence of specific symptoms or signs.
Read the full text of the article:
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa, A., et al. (2024).
European Urology Oncology. doi.org/10.1016/j.euo.2023.12.005.
Source: Comprehensive Cancer Center Vienna of MedUni Vienna
This entry was posted on gennaio 20, 2024 a 6:08 am and is filed under News-research. Tagged: andrology, diagnostics, oncology, urology. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a responseor trackback from your own site.